Chronic obstructive pulmonary disease (COPD) is a complex and heterogeneous disease,
and there is a clinical need for validated markers and biomarkers that can contribute to the …

Chronic Obstructive Pulmonary Disease (COPD) is a leading cause of morbidity and
mortality worldwide. Disease severity evaluation was based on airflow limitation for many …

Chronic obstructive pulmonary disease (COPD) is a progressive disease of the lung
characterized by irreversible airflow obstruction, persistent airway inflammation, and …

The study of airway diseases continues to present several challenges for modern medicine.
The different disease presentations with variables and overlapping features may result in a …

Pheno-/endotyping chronic obstructive pulmonary disease (COPD) is really important
because it provides patients with precise and personalized medicine. The central concept of …

COPD is a heterogeneous condition, the onset and trajectory of which is influenced not only
by tobacco exposure but also an individual's genetics and the exposures they accumulate …

Personalized medicine and chronic obstructive pulmonary dise... : Current Opinion in
Pulmonary Medicine Personalized medicine and chronic obstructive pulmonary disease …

ABSTRACT Chronic Obstructive Pulmonary Disease (COPD) is a heterogeneous and
complex disease with great morbidity and mortality. Despite the new developments in the …

Chronic obstructive pulmonary disease (COPD) is one of the major causes of morbidity and
mortality in the world. Regrettably, there are no biomarkers to objectively diagnose COPD …

Currently, with exception of lung function tests, there are no well validated biomarkers or
surrogate endpoints that can be used to establish efficacy of novel drugs for chronic …